Virios Therapeutics, Inc. ( (DWTX) ) has released its Q4 earnings. Here is a breakdown of the information Virios Therapeutics, Inc. presented to its investors.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Dogwood Therapeutics, Inc. is a development-stage biopharmaceutical company focused on creating innovative treatments for pain and fatigue-related disorders, with a pipeline that includes non-opioid analgesics and antiviral programs.